Real-world data for heart failure: Closing evidence gaps across the patient journey
The evolution of heart failure treatment and research Heart failure remains one of the most...
The evolution of heart failure treatment and research Heart failure remains one of the most...
The rise of GLP-1 therapies and the evolution of obesity treatment Over 40% of adults in the U.S....
Turning claims into interoperable evidence More means more. In a world where anyone can make...
Recently, Omada Health and HealthVerity announced a press release highlighting their collaboration...
This is part three of a three-part series on the essential qualities of claims data for life...
This is part two of a three-part series (read part 1, part 3) on the essential qualities of claims...
This is part one of a three-part series (read part 2, part 3) on the essential qualities of claims...
As high-value therapies become the new norm,life sciences teams need closed claims data that...
Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system (CNS) and can lead to significant disability over time. It remains the most common inflammatory neurological condition worldwide and in the United States alo...